Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

Applied Biosystems Group and Celera Genomics Group Third Quarter FY 2001 Financial Results Scheduled for Release

Norwalk, CT - April 09, 2001

Applera Corporation announced today that it will issue fiscal year 2001 third quarter results for Applied Biosystems Group (NYSE: ABI) and Celera Genomics Group (NYSE: CRA) on Thursday. April 26, 2001. Results will be released before the opening of trading on the New York Stock Exchange.

Tony L. White, Applera Corporationís chief executive officer, will lead a conference call to discuss these results and to address managementís current financial outlook for the company. Dennis L. Winger, Appleraís chief financial officer, and senior managers from Applied Biosystems and Celera Genomics, will join Mr. White to answer questions from securities analysts and investment professionals. The call is scheduled for 10:00 a.m. (Eastern Time). Investors, securities analysts, and representatives of the media calling from the US or Canada who would like to participate should dial (800) 230-1092 (ask for Third Quarter Earnings Release) between 9:45 and 10:00 a.m. on April 26. International participants should call (+1) 612.288.0337. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit either and go to the Investor Relations section of the web site, or and go to the In the News section, or and go to the Press Releases section.

Applera Corporation comprises two operating groups. The Applied Biosystems Group, with sales of $1.4 billion during fiscal 2000, develops and markets instrument-based systems, reagents, software and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, CA. The Celera Genomics Group, headquartered in Rockville, MD, is a definitive source of genomic and related medical information. Information about the company, including reports and other information filed by the company with the U.S. Securities and Exchange Commission, is available on the world wide web at or by phoning 800.762.6923.

Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.